|
|
| (11) | Number of the document | |
| (68) | Number of the document | 4129330 |
| (21) | Application number for Supplementary Protection Certificate | PA 2024 503 |
| (22) | Date of filing the application | 2024-03-05 |
| (41) | Date of publication of the application | 2024-03-25 |
| Date of publication of SPC | ||
| (24) | Date of coming into effect of SPC |
| (71) |
Takeda Vaccines, Inc. ,
75 Sidney Street, Cambridge, MA 02139,
US
The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services , 4770 Buford Highway Technology Transfer Office (K79), Atlanta, GA 30341, US |
| (73) |
Takeda Vaccines, Inc. ,
75 Sidney Street, Cambridge, MA 02139,
US
The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services , 4770 Buford Highway Technology Transfer Office (K79), Atlanta, GA 30341, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/22/1699, 2022-12-05 |
| (95) | Denge karštligės keturvalentė vakcina (gyva, susilpninta) |
| SPC application published |